These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 26453748)
1. The Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells. Redeker A; Welten SP; Baert MR; Vloemans SA; Tiemessen MM; Staal FJ; Arens R J Immunol; 2015 Nov; 195(10):4792-801. PubMed ID: 26453748 [TBL] [Abstract][Full Text] [Related]
2. Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion. Wong P; Pamer EG J Immunol; 2004 Feb; 172(4):2171-6. PubMed ID: 14764683 [TBL] [Abstract][Full Text] [Related]
3. Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production. O'Brien S; Thomas RM; Wertheim GB; Zhang F; Shen H; Wells AD J Immunol; 2014 Jun; 192(11):5118-29. PubMed ID: 24778448 [TBL] [Abstract][Full Text] [Related]
4. Differential outcome of IL-2/anti-IL-2 complex therapy on effector and memory CD8+ T cells following vaccination with an adenoviral vector encoding EBV epitopes. Smith C; Martinez M; Peet J; Khanna R J Immunol; 2011 May; 186(10):5784-90. PubMed ID: 21482735 [TBL] [Abstract][Full Text] [Related]
5. 4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8+ T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling. Oh HS; Choi BK; Kim YH; Lee DG; Hwang S; Lee MJ; Park SH; Bae YS; Kwon BS PLoS One; 2015; 10(5):e0126765. PubMed ID: 25962156 [TBL] [Abstract][Full Text] [Related]
6. Development of IFN-gamma-producing CD8+ gamma delta+ T lymphocytes and IL-2-producing CD4+ alpha beta+ T lymphocytes during contact sensitivity. Dieli F; Asherson GL; Sireci G; Dominici R; Sciré E; Salerno A J Immunol; 1997 Mar; 158(6):2567-75. PubMed ID: 9058788 [TBL] [Abstract][Full Text] [Related]
7. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity. Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059 [TBL] [Abstract][Full Text] [Related]
8. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation. Wu Z; Xu Y J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116 [TBL] [Abstract][Full Text] [Related]
9. Anion exchanger 2 is critical for CD8(+) T cells to maintain pHi homeostasis and modulate immune responses. Concepcion AR; Salas JT; Sarvide S; Sáez E; Ferrer A; López M; Portu A; Banales JM; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF Eur J Immunol; 2014 May; 44(5):1341-51. PubMed ID: 24515893 [TBL] [Abstract][Full Text] [Related]
10. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size. Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775 [TBL] [Abstract][Full Text] [Related]
11. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes. Kim S; Shen T; Min B J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092 [TBL] [Abstract][Full Text] [Related]
12. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy. Jackson RJ; Worley M; Trivedi S; Ranasinghe C Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041 [TBL] [Abstract][Full Text] [Related]
13. CD8+ T cells produce IL-2, which is required for CD(4+)CD25+ T cell regulation of effector CD8+ T cell development for contact hypersensitivity responses. Kish DD; Gorbachev AV; Fairchild RL J Leukoc Biol; 2005 Sep; 78(3):725-35. PubMed ID: 16000396 [TBL] [Abstract][Full Text] [Related]
14. CD4(+) T cells stimulate memory CD8(+) T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretion. Shi M; Hao S; Chan T; Xiang J J Leukoc Biol; 2006 Dec; 80(6):1354-63. PubMed ID: 16980510 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy. Mueller K; Schweier O; Pircher H Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743 [TBL] [Abstract][Full Text] [Related]
17. The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells. Fearon DT; Carr JM; Telaranta A; Carrasco MJ; Thaventhiran JE Immunol Rev; 2006 Jun; 211():104-18. PubMed ID: 16824121 [TBL] [Abstract][Full Text] [Related]
18. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}. Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921 [TBL] [Abstract][Full Text] [Related]
19. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response. Apte SH; Groves P; Olver S; Baz A; Doolan DL; Kelso A; Kienzle N J Immunol; 2010 Jul; 185(2):998-1004. PubMed ID: 20562261 [TBL] [Abstract][Full Text] [Related]
20. IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs. Emmerich J; Mumm JB; Chan IH; LaFace D; Truong H; McClanahan T; Gorman DM; Oft M Cancer Res; 2012 Jul; 72(14):3570-81. PubMed ID: 22581824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]